P3 Health Partners Inc.
PIII
$10.19
$1.1012.08%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | 1.46B | 1.49B | 1.50B | 1.48B | 1.40B |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 1.46B | 1.49B | 1.50B | 1.48B | 1.40B |
Cost of Revenue | 1.54B | 1.55B | 1.56B | 1.52B | 1.39B |
Gross Profit | -73.71M | -64.17M | -58.92M | -40.20M | 8.73M |
SG&A Expenses | 114.01M | 117.58M | 120.13M | 113.45M | 113.62M |
Depreciation & Amortization | 84.96M | 85.57M | 86.06M | 86.54M | 86.59M |
Other Operating Expenses | 43.17M | 45.74M | 53.70M | 12.43M | -18.23M |
Total Operating Expenses | 1.78B | 1.80B | 1.82B | 1.73B | 1.58B |
Operating Income | -315.85M | -313.06M | -318.80M | -252.62M | -173.25M |
Income Before Tax | -315.51M | -301.63M | -305.99M | -249.14M | -179.56M |
Income Tax Expenses | 4.40M | 3.39M | 4.39M | 1.20M | 5.22M |
Earnings from Continuing Operations | -319.91 | -305.02 | -310.38 | -250.34 | -184.78 |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | 173.94M | 167.39M | 174.53M | 147.64M | 115.30M |
Net Income | -145.97M | -137.63M | -135.85M | -102.69M | -69.48M |
EBIT | -315.85M | -313.06M | -318.80M | -252.62M | -173.25M |
EBITDA | -230.89M | -227.49M | -232.74M | -166.08M | -86.66M |
EPS Basic | -52.02 | -50.19 | -51.77 | -37.67 | -29.13 |
Normalized Basic EPS | -10.61 | -10.00 | -8.51 | -3.40 | 1.36 |
EPS Diluted | -57.26 | -58.39 | -59.97 | -60.90 | -51.16 |
Normalized Diluted EPS | -10.54 | -9.92 | -8.43 | -3.31 | 1.11 |
Average Basic Shares Outstanding | 12.10M | 11.56M | 10.68M | 10.65M | 9.70M |
Average Diluted Shares Outstanding | 12.15M | 11.71M | 10.83M | 10.80M | 13.76M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |